Curis Lifesciences IPO Details
| IPO Open Date | November 7, 2025 |
| IPO Close Date | November 11, 2025 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹120 to ₹128 Per Share |
| Issue Size | Approx ₹27.52 Crores |
| Fresh Issue | Approx ₹27.52 Crores |
| Issue Type | Book Built Issue |
| IPO Listing | NSE SME |
| DRHP Draft Prospectus |  |
| RHP Draft Prospectus | |
Curis Lifesciences IPO Review & Key Points
- Review:
Curis Lifesciences IPO Market Lot
The Curis Lifesciences IPO minimum market lot is 2,000 shares with ₹2,56,000 application amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 2 | 2,000 | ₹2,56,000 |
| Retail Maximum | 2 | 2,000 | ₹2,56,000 |
| S-HNI Minimum | 3 | 3,000 | ₹3,84,000 |
| S-HNI Maximum | 7 | 7,000 | ₹8,96,000 |
| B-HNI Minimum | 8 | 8,000 | ₹10,24,000 |
IPO Reservation
| Investor Category | Share Offered | -% Shares |
| Anchor Investor | 6,09,000 Shares | 28.33% |
| QIB (Ex. Anchor) | 4,09,000 Shares | 19.02% |
| NII Shares Offered | 3,08,000 Shares | 14.33% |
| Retail Shares Offered | 7,16,000 Shares | 33.30% |
Curis Lifesciences IPO Anchor Investors
| Anchor Bidding Date | November 6, 2025 |
| Anchor Investors List | |
| Shares Offered | 6,09,000 Shares |
| Anchor Size | 7.80 Cr. |
| lock-in period end date 50% shares (30 Days) | December 12, 2025 |
| lock-in period end date 50% shares (90 Days) | February 10, 2026 |
Curis Lifesciences IPO Dates
The Curis Lifesciences IPO date is November 7 and the close date is November 11. The Curis Lifesciences IPO allotment will be finalized on November 12 and the IPO listing on November 14.
| IPO Open Date: | November 7, 2025 |
| IPO Close Date: | November 11, 2025 |
| Basis of Allotment: | November 12, 2025 |
| Refunds: | November 13, 2025 |
| Credit to Demat Account: | November 13, 2025 |
| IPO Listing Date: | November 14, 2025 |
| IPO Bidding Cut-off Time: | November 11, 2025 – 5 PM |
Promoters and Holding Pattern
The promoters of the company are Mr. Dharmesh Dashrathbhai Patel, Mr. Siddhant Jayantibhai Pawasia, Mr. Piyush Gordhanbhai Antala and Mr. Jaimik Mansukhbhai Patel..
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 59,34,434 | 92.68% |
| Promoter Holding Post Issue | 80,84,434 | 68.03% |
Objects of the Issue & Utilisation of proceeds
| Purpose | Crores |
| Capital Expenditure towards Upgradation/Improvement of the existing Manufacturing Facilities | ₹2.44 |
| Capital Expenditure towards Construction of a Storage Facility | ₹3.62 |
| Pre-payment/Repayment of outstanding Secured Loans | ₹1.86 |
| Product Registrations in other countries | ₹2.69 |
| Funding our Working Capital Requirements | ₹11.25 |
| General Corporate Purposes | ₹- |
About Curis Lifesciences IPO
Curis Lifesciences Limited, founded in 2010, is one of the leading pharmaceutical companies that manufactures a wide range of pharmaceutical products, including Tablets, Capsules, External Preparations, Oral liquids, and Sterile Ophthalmic Ointments. The company gets ready-made goods from manufacturers and distributes them to wholesalers and other clients nationwide. The company had a total of 95 permanent employees as of July 31, 2025.
Curis Lifescience makes medicine in India and abroad under contract or license agreement, as well as for its own brand. In addition to its two own-brand clients in Yemen and Kenya, the firm contracts with more than 100 corporate clients. Moreover, the company consists of a state-of-the-art factory in Sanand, Gujarat, through which they follow strict quality control checks to make sure each of their products is safe and works well.
Curis Lifesciences IPO Company Financial Report
Amount ₹ in Crores
| Period Ended | Revenue | Expense | PAT | Assets |
| 2023 | ₹36.42 | ₹34.23 | ₹1.88 | ₹29.75 |
| 2024 | ₹35.87 | ₹28.70 | ₹4.87 | ₹33.88 |
| 2025 | ₹49.65 | ₹41.38 | ₹6.11 | ₹42.53 |
| July 2025 | ₹19.51 | ₹15.79 | ₹2.87 | ₹56.29 |
Curis Lifesciences IPO Valuation – FY2025
Check Curis Lifesciences IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | 55.25% |
| ROCE: | 27.83% |
| EBITDA Margin: | 19.41% |
| PAT Margin: | 12.43% |
| Debt to equity ratio: | 0.96 |
| Earning Per Share (EPS): | ₹10.29 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 37.62% |
| Net Asset Value (NAV): | ₹27.34 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Sotac Pharmaceuticals Limited | 4.32 | 18.30 | 9.00% | 47.99 | 64.76 Cr. |
| Lincoln Pharmaceuticals Limited | 41.11 | 12.21 | 12.27% | 335.34 | 645.71 Cr. |
IPO Lead Managers aka Merchant Bankers
- Finaax Capital Advisors Private Limited
Company Address
Curis Lifesciences Ltd.
PF-23, GIDC Sanand – II,
Industrial Estate,
Sanand
Ahmedabad, Gujarat, 382110
Phone: +91 99045 22543
Email: [email protected]
Website: https://curisls.com/
IPO Registrar
MUFG Intime India Pvt.Ltd.
Phone: +91-22-4918 6270
Email: [email protected]
Website: https://in.mpms.mufg.com/Initial_Offer/public-issues.html
Curis Lifesciences IPO FAQs
What is Curis Lifesciences IPO?
When Curis Lifesciences IPO will open for subscription?
What is Curis Lifesciences IPO Investors Portion?
How to Apply the Curis Lifesciences IPO?
What is Curis Lifesciences IPO Issue Size?
What is Curis Lifesciences IPO Price Band?
What is Curis Lifesciences IPO Lot Size?
What is the Curis Lifesciences IPO Allotment Date?
What is the Curis Lifesciences IPO Listing Date?
Note: The Curis Lifesciences IPO price band and date are officially announced. The (Curis Lifesciences IPO grey market premium) will be added to the IPO GMP page as it will start).
